Abstract：Objective To investigate the effects of ω-3 polyunsaturated fatty acids (ω-3 PUFAs) on the apoptosis of thymic and splenic lymphocytes in rats with sepsis. Methods A total of 80 female Sprague-Dawley rats aged 7-8 weeks were randomly divided into model group, conventional lipid emulsion group (0.1 g/kg daily), low-dose ω-3 PUFAs group (0.1 g/kg daily), middle-dose ω-3 PUFAs group (0.2 g/kg daily), and high-dose ω-3 PUFAs group (0.3 g/kg daily). Cecal ligation and puncture were used to establish a rat model of sepsis. The treatment groups were then given tail vein injection of lipid emulsion or glucose diluents of ω-3 PUFAs at different doses, and the model group was given glucose injection via the tail vein at the same dose. According to the time of sacrifice, each group was further divided into 24-hour and 72-hour subgroups, with 8 rats in each subgroup. Hematoxylin and eosin staining was used to observe the pathological changes in the thymus and spleen. TUNEL was used to measure the apoptosis rates of thymic and splenic lymphocytes. Results In the three ω-3 PUFAs groups, the rats had a complete thymic lobular structure and clear structures of the cortex and medulla. In the model and the conventional lipid emulsion groups, the boundaries of the cortex and medulla were unclear and the number of lymphocytes was significantly reduced. In the ω-3 PUFAs groups, the structure of the red and white pulp of the spleen was maintained with the presence of splenic follicles, while in the model and the conventional lipid emulsion groups, the structure of the red and white pulp of the spleen was disordered and splenic follicles were significantly reduced or disappeared. Compared with the model and the conventional lipid emulsion groups, the ω-3 PUFAs groups showed significant reductions in the apoptosis rates of thymic and splenic lymphocytes at 24 and 72 hours (P < 0.01). Compared with the low-dose ω-3 PUFAs group, the high-dose ω-3 PUFAs group had significantly reduced apoptosis rates of splenic lymphocytes at 24 and 72 hours (P < 0.05). Conclusions ω-3 PUFAs can reduce the apoptosis of thymic and splenic lymphocytes in rats with sepsis in a dose-dependent manner.
MIAO Hong-Jun,WANG Dan,GE Xu-Hua et al. Effects of ω-3 polyunsaturated fatty acids on lymphocyte apoptosis rate in rats with sepsis[J]. CJCP, 2017, 19(3): 355-360.
Martin GS. Sepsis, severe sepsis and septic shock:changes in incidence, pathogens and outcomes[J]. Expert Rev Anti Infect Ther, 2012, 10(6):701-706.
[2]
Novosad SA, Sapiano MR, Grigg C, et al. Vital signs:epidemiology of sepsis:prevalence of health care factors and opportunities for prevention[J]. MMWR Morb Mortal Wkly Rep, 2016, 65(33):864-869.
[3]
Moore LJ, McKinley BA, Turner KL, et al. The epidemiology of sepsis in general surgery patients[J]. J Trauma, 2011, 70(3):672-680.
[4]
de Souza DC, Barreira ER, Faria LS. The epidemiology of sepsis in childhood[J]. Shock, 2017, 47(1S Suppl 1):2-5.
[5]
de Souza DC, Shieh HH, Barreira ER, et al. Epidemiology of sepsis in children admitted to PICUs in South America[J]. Pediatr Crit Care Med, 2016, 17(8):727-734.
[6]
Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis:a novel understanding of the disorder and a new therapeutic approach[J]. Lancet Infect Dis, 2013, 13(3):260-268.
[7]
Luan YY, Dong N, Xie M, et al. The significance and regulatory mechanisms of innate immune cells in the development of sepsis[J]. J Interferon Cytokine Res, 2014, 34(1):2-15.
[8]
Chen S, Zhang H, Pu H, et al. n-3 PUFA supplementation benefits microglial responses to myelin pathology[J]. Sci Rep, 2014, 4:7458.
[9]
Garcia M, Greco LF, Favoreto MG, et al. Effect of supplementing essential fatty acids to pregnant nonlactating Holstein cows and their preweaned calves on calf performance, immune response, and health[J]. J Dairy Sci, 2014, 97(8):5045-5064.
[10]
Rittirsch D, Huber-Lang MS, Flierl MA, et al. Immunodesign of experimental sepsis by cecal ligation and puncture[J]. Nat Protoc, 2009, 4(1):31-36.
[11]
Heller AR, Rössler S, Litz RJ, et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome[J]. Crit Care Med, 2006, 34(4):972-979.
Pathan N, Franklin JL, Eleftherohorinou H, et al. Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase[J]. Crit Care Med, 2011, 39(7):1692-1711.
[14]
Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure[J]. JAMA, 2011, 306(23):2594-2605.
[15]
Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression:a common syndrome and new horizon for surgical intensive care[J]. J Trauma Acute Care Surg, 2012, 72(6):1491-1501.
[16]
Lang JD, Matute-Bello G. Lymphocytes, apoptosis and sepsis:making the jump from mice to humans[J]. Crit Care, 2009, 13(1):109.
[17]
Hotchkiss RS, Opal S. Immunotherapy for sepsis-a new approach against an ancient foe[J]. N Engl J Med, 2010, 363(1):87-89.
[18]
Kohli P, Levy BD. Resolvins and protectins:mediating solutions to inflammation[J]. Br J Pharmacol, 2009, 158(4):960-971.
[19]
Park KS, Lim JW, Kim H. Inhibitory mechanism of omega-3 fatty acids in pancreatic inflammation and apoptosis[J]. Ann N Y Acad Sci, 2009, 1171:421-427.
[20]
Tayyebi-Khosroshahi H, Houshyar J, Tabrizi A, et al. Effect of omega-3 fatty acid on oxidative stress in patients on hemodialysis[J]. Iran J Kidney Dis, 2010, 4(4):322-326.
[21]
Garrel C, Alessandri JM, Guesnet P, et al. Omega-3 fatty acids enhance mitochondrial superoxide dismutase activity in rat organs during postnatal development[J]. Int J Biochem Cell Biol, 2012, 44(1):123-131.
[22]
Zugno AI, Chipindo HL, Volpato AM, et al. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia[J]. Neuroscience, 2014, 259:223-231.
